meningococcal meningitis), less immediately (e.g. Most are transient with few untoward sequelae but some can cause serious, recurrent, disseminated or persistent lesions – especially in immunocompromised persons (particularly in neutropenic patients, those with organ transplants, and those with human immunodeficiency virus/acquired immunodeficiency syndrome ) – or can be life-threatening immediately (e.g. Diagnostic laboratories also have a requirement to notify the HPA of specified causative agents they identify in tests on human samples.īacterial infections are common. emerging or new infections, or cases of contamination (such as with chemicals or radiation) – particularly if there is a risk of transmission to others. As well as notifications of the infectious diseases specified below, the 2010 regulations also require GMPs to notify cases of ‘other infections or of contamination which they believe present, or could present, a significant risk to human health’, e.g. The proper officers are required weekly to inform the Health Protection Agency (HPA) Centre for Infections (CfI) of the details of each case of each disease that has been notified.
The GMP should fill out a notification certificate immediately on diagnosis without waiting for laboratory confirmation and ensure that it reaches the officer within 3 days (telephone if urgent). Registered general medical practitioners (GMPs) in England and Wales have ‘a statutory duty to notify a “proper officer” of the Local Authority of suspected cases of certain infectious diseases’ – usually the consultant in communicable disease control (CCDC). New (amended) regulations for clinical notifications came into force on 6 April 2010 ( Box 21.2 Notification of a number of specified infectious diseases is required in UK under the Public Health (Infectious Diseases) 1988 Act and the Public Health (Control of Diseases) 1984 Act.
0 kommentar(er)
